Dhifaf Sarhan

Affiliations: 
Oncology and Pathology Karolinska Instituet 
Google:
"Dhifaf Sarhan"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chen Z, Yang Y, Neo SY, et al. (2021) Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25 /CD54 NK cells. Embo Reports. e51329
Evren E, Ringqvist E, Tripathi KP, et al. (2020) Distinct developmental pathways from blood monocytes generate human lung macrophage diversity. Immunity
La Fleur L, Botling J, He F, et al. (2020) Targeting MARCO and IL-37R on immunosuppressive macrophages in lung cancer blocks regulatory T cells and supports cytotoxic lymphocyte function. Cancer Research
Eisinger S, Sarhan D, Boura VF, et al. (2020) Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells. Proceedings of the National Academy of Sciences of the United States of America
Sarhan D, Wang J, Sunil Arvindam U, et al. (2020) Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function. Jci Insight
Sarhan D, Miller JS. (2019) Assessing Canonical and Adaptive Natural Killer Cell Function in Suppression Assays In Vitro. Methods in Molecular Biology (Clifton, N.J.). 1913: 153-166
Sarhan D, Hippen KL, Lemire A, et al. (2018) Adaptive NK cells resist regulatory T cell suppression driven by IL-37. Cancer Immunology Research
de Witte MA, Sarhan D, Davis Z, et al. (2018) Early Reconstitution of NK and Γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation
Bachanova V, Sarhan D, DeFor TE, et al. (2017) Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells. Cancer Immunology, Immunotherapy : Cii
Sarhan D, Leijonhufvud C, Murray S, et al. (2017) Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer. Oncoimmunology. 6: e1338238
See more...